Validation of improvement effects on sleep quality by test-food intakes - Validation of improvement effects on sleep quality by test-food intakes

CPCC Company Limited0 sites60 target enrollmentAugust 29, 2023

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: CPCC Company Limited
Enrollment: 60
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

August 29, 2023

End Date

October 23, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

CPCC Company Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Subjects \- \- (1\) taking in sleep\-affecting foods, not less than three times a week, (2\) who will take medicines which might affect the test (e.g., sleeping pill) during the test period, (3\) with not less than 30\.0 kg/m2 of BMI, (4\) with sleep\-apnea syndrome, (5\) with previous medical history of sleep disorder, (6\) with a continuous medical treatment for sleep disorder, (7\) who are now under medical treatment for mental disorders, or have been diagnosed as depression with a strong sense of stress and fear. (8\) with an overnight trip during the test period, (9\) with extremely irregular dietary habit/life rhythm, (10\) with a serious sleep\-affecting rhinitis, (11\) with excessive alcohol intake, (12\) sleeping with their family in the same room, and might be woken up by the family during sleep, (13\) with medical history of serious diseases, (14\) with pregnancy, possibly one, or lactating, (15\) with drug/food allergy, (16\) being under another clinical test (medicine or health food), or participated in that within the last 4 weeks, or will join that after the consent, (17\) who donated their blood components or blood (200 mL) within the last month, (18\) who donated his blood (400 mL) within the last 3 months, (19\) who donated her blood (400 mL) within the last 4 months, (20\) being collected in total of his blood (1200 mL) within the last 12 months and in this study, (21\) being collected in total of her blood (800 mL) within the last 12 months and in this study, (22\) being determined as ineligible for participation by the principal/sub investigator \- \- .